69 related articles for article (PubMed ID: 23302311)
1. Pediatric adrenocortical carcinoma: clinical features and application of neoadjuvant chemotherapy.
Lin Y; Yang S; Yang W; Cheng H; Chang X; Zhu Z; Feng J; Han J; Ren Q; Chang S; Liu S; Yu T; Hou B; Li P; Meng D; Zhang X; Qin H; Wang H
Eur J Med Res; 2023 Oct; 28(1):411. PubMed ID: 37814272
[TBL] [Abstract][Full Text] [Related]
2. [Adrenal cortical carcinoma in children: a clinicopathological analysis of 25 cases].
Wang RF; Guan WB; Li LX; Qiao M; Jiang RQ; Wang LF
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):40-45. PubMed ID: 38178745
[No Abstract] [Full Text] [Related]
3. Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan.
Nakanishi S; Fukushima Y; Inokuchi J; Hakariya T; Kakinoki H; Enokida H; Chikui K; Matsuoka H; Shin T; Mukai S; Kamba T; Eto M; Imamura R; Noguchi M; Igawa T; Haga N; Kamoto T; Fujimoto N; Saito S
Int J Urol; 2024 May; 31(5):484-491. PubMed ID: 38193650
[TBL] [Abstract][Full Text] [Related]
4. Case report: A rare combination of aldosterone-secreting adrenocortical carcinoma and papillary thyroid carcinoma with Graves' disease.
Zhang Y; Yu J; Fan C; Wang F; Liu H; Chen K
Front Endocrinol (Lausanne); 2024; 15():1310408. PubMed ID: 38645425
[TBL] [Abstract][Full Text] [Related]
5. High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study.
Catalano R; Altieri B; Angelousi A; Arosio M; Bravi F; Canu L; Croci GA; Detomas M; Esposito E; Ferrante E; Ferrero S; Fuss CT; Kaltsas G; Kimpel O; Landwehr LS; Luconi M; Morelli V; Nesi G; Nozza E; Sbiera S; Serban AL; Ronchi CL; Mantovani G; Peverelli E
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068896
[TBL] [Abstract][Full Text] [Related]
6. Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis.
Turla A; Laganà M; Cremaschi V; Zamparini M; De Maria L; Consoli F; Abate A; Tamburello M; Alberti A; Sigala S; Grisanti S; Fontanella MM; Cosentini D; Berruti A
J Endocrinol Invest; 2024 Jan; 47(1):223-234. PubMed ID: 37354248
[TBL] [Abstract][Full Text] [Related]
7. [Guidelines of the French National ENDOCAN-COMETE, Association of Endocrine Surgery, Society of Urology for the management of adrenocortical carcinoma].
Libé R; Haissaguerre M; Renaudin K; Faron M; Decaussin-Petrucci M; Deschamps F; Gimenez-Roqueplo AP; Mirallie E; Murez T; Pattou F; Rocher L; Taïeb D; Savoie PH; Tabarin A; Bertherat J; Baudin E; de la Fouchardière C
Bull Cancer; 2023 Jun; 110(6):707-730. PubMed ID: 37061367
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry.
Balderrama-Brondani V; Griffin AM; Owen TJ; Merriman KW; Chahla BB; Varghese J; Jimenez C; Waguespack SG; Graham PH; Perrier ND; Fisher SB; Karam JA; Shah AY; Campbell M; Hassan MM; Habra MA
Endocr Pract; 2024 Jan; 30(1):25-30. PubMed ID: 37858722
[TBL] [Abstract][Full Text] [Related]
9. Small Non-coding RNA Abundance in Adrenocortical Carcinoma: A Footprint of a Rare Cancer.
Koduru SV; Leberfinger AN; Ravnic DJ
J Genomics; 2017; 5():99-118. PubMed ID: 28943972
[No Abstract] [Full Text] [Related]
10. A case of metastatic adrenocortical carcinoma diagnosed with steroidogenic factor-1 in a sprague-dawley rat.
Takai Y; Sano T; Watanabe T; Fukuda R
J Toxicol Pathol; 2013 Sep; 26(3):319-23. PubMed ID: 24155566
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic Vitiligo Associated With Adrenocortical Carcinoma.
Goodkin DA; Failor RA; Habra MA
JCEM Case Rep; 2024 May; 2(5):luae070. PubMed ID: 38707658
[TBL] [Abstract][Full Text] [Related]
12. Myxoid adrenocortical adenoma with a pseudoglandular pattern: a case report and literature review.
Zeng Z; Gu LJ; Zhou ZY; Liu L; Yan HL; Huang YB; Wang ZS; Chen J; Yuan JP
Int J Clin Exp Pathol; 2017; 10(8):8908-8915. PubMed ID: 31966759
[TBL] [Abstract][Full Text] [Related]
13. The challenge of developmental therapeutics for adrenocortical carcinoma.
Costa R; Carneiro BA; Tavora F; Pai SG; Kaplan JB; Chae YK; Chandra S; Kopp PA; Giles FJ
Oncotarget; 2016 Jul; 7(29):46734-46749. PubMed ID: 27102148
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?
Bulzico D; Faria PAS; Maia CB; de Paula MP; Torres DC; Ferreira GM; Pires BRB; Hassan R; Abdelhay E; Vaisman M; Vieira Neto L
Endocrine; 2017 Nov; 58(2):276-288. PubMed ID: 28887601
[TBL] [Abstract][Full Text] [Related]
16. Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms.
Erickson LA; Jin L; Sebo TJ; Lohse C; Pankratz VS; Kendrick ML; van Heerden JA; Thompson GB; Grant CS; Lloyd RV
Endocr Pathol; 2001; 12(4):429-35. PubMed ID: 11949624
[TBL] [Abstract][Full Text] [Related]
17. IGF2 role in adrenocortical carcinoma biology.
Pereira SS; Monteiro MP; Costa MM; Moreira Â; Alves MG; Oliveira PF; Jarak I; Pignatelli D
Endocrine; 2019 Nov; 66(2):326-337. PubMed ID: 31378849
[TBL] [Abstract][Full Text] [Related]
18. Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
Nakamura Y; Yamazaki Y; Felizola SJ; Ise K; Morimoto R; Satoh F; Arai Y; Sasano H
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):399-410. PubMed ID: 26038208
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
